Neutrophil gelatinase-associated lipocalin: A promising biomarker for human acute kidney injury

Biomarkers in Medicine

Volumn 4, Issue 2, 2010, Pages 265-280

  Devarajan, Prasad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Acute renal failure; Biomarkers; Lipocalin; Nephrotoxicity; Neutrophil gelatinase associated lipocalin

Indexed keywords

CONTRAST MEDIUM; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TROPONIN;

ACUTE KIDNEY FAILURE; CONTRAST INDUCED NEPHROPATHY; CREATININE URINE LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION PROFILING; HEART SURGERY; HUMAN; INTENSIVE CARE; KIDNEY TRANSPLANTATION; NONHUMAN; PATIENT MONITORING; PREDICTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN URINE LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CONTRAST MEDIA; EARLY DIAGNOSIS; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; LIPOCALINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, ACUTE; SEVERITY OF ILLNESS INDEX;

EID: 77951458867     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.10.12     Document Type: Review

References (116)

1. Murray PT, Devarajan P, Level AS et al.: A framework and key research questions in AKI diagnosis and staging in different environments. Clin. J. Am. Soc. Nephrol. 3, 864-868 (2008).
2. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J. Am. Soc. Nephrol. 17, 1503-1520 (2006). (Pubitemid 43841396)
3. Nickolas TL, Barasch J, Devarajan P: Biomarkers in acute and chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 17, 127-132 (2008). (Pubitemid 351253035)
4. Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand. J. Clin. Lab. Invest. 68, 89-94 (2008). (Pubitemid 351883665)
5. Devarajan P: Neutrophil gelatinase-associated lipocalin - an emerging troponin for kidney injury. Nephrol. Dial. Transplant. 23, (12), 3737-3743 (2008). (Pubitemid 351883665)
6. Parikh CR, Devarajan P: New biomarkers of acute kidney injury. Crit. Care Med. 36(4 Suppl.), 159-165 (2008). (Pubitemid 351253035)
7. Uchino S, Kellum JA, Bellomo R et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294(7), 813-818 (2005). (Pubitemid 41175724)
8. Chertow GM, Soroko SH, Paganini EP et al.: Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 70, 1120-1126 (2006). (Pubitemid 44344083)
9. Hoste EA, Kellum JA: RIFLE criteria provide robust assessment of kidney dysfunction and correlate with hospital mortality. Crit. Care Med. 34(7), 2016-2017 (2006).
10. Radhakrishnan J, Kiryluk K: Acute renal failure outcomes in children and adults. Kidney Int. 69(1), 17-19 (2006). (Pubitemid 43117733)
11. Ympa YP, Sakr Y, Reinhart K, Vincent JL: Has mortality from acute renal failure decreased? A systematic review of the literature. Am. J. Med. 118(8), 827-832 (2005). (Pubitemid 41097456)
12. Bellomo R: The epidemiology of acute renal failure: 1975 versus 2005. Curr. Opin. Crit. Care 12(6), 557-560 (2006). (Pubitemid 44673431)
13. Fischer MJ, Brimhall BB, Lezotte DC, Glazner JE, Parikh CR: Uncomplicated acute renal failure and hospital resource utilization: a retrospective multicenter analysis. Am. J. Kidney Dis. 46(6), 1049-1057 (2005).
14. Doi K, Yuen PS, Eisner C et al.: Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J. Am. Soc. Nephrol. 20(6), 1217-1221 (2009).
15. Waikar SS, Bonventre JV: Creatinine kinetics and the definition of acute kidney injury. J. Am. Soc. Nephrol. 20(3), 672-679 (2009).
16. Nguyen MT, Devarajan P: Biomarkers for the early detection of acute kidney injury. Pediatr. Nephrol. 23(12), 2151-2157 (2008). (Pubitemid 351253035)
17. Devarajan P: Emerging biomarkers of acute kidney injury. Contrib. Nephrol. 156, 203-212 (2007).
18. Devarajan P: Proteomics for biomarker discovery in acute kidney injury. Semin. Nephrol. 27, 637-651 (2007). (Pubitemid 350180173)
19. Devarajan P: Proteomics for the investigation of acute kidney injury. Contrib. Nephrol. 160, 1-16 (2008). (Pubitemid 351398278)
20. Devarajan P, Parikh C, Barasch J: Case 31-2007: a man with abdominal pain and elevated creatinine. N. Engl. J. Med. 358(3), 312 (2008).
21. Xu SY, Carlson M, Engström A, Garcia R, Peterson CG, Venge P: Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand. J. Clin. Lab. Invest. 54(5), 365-376 (1994). (Pubitemid 24246789)
22. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 286, 10425-10432 (1993). (Pubitemid 23150227)
23. Cowland JB, Borregaard N: Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45, 17-23 (1997). (Pubitemid 27449379)
24. Flower DR: Experimentally determined lipocalin structures. Biochim. Biophys. Acta 1482, 46-56 (2000).
25. Goetz DH, Holmes MA, Borregaard N et al.: The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10, 1033-1043 (2002). (Pubitemid 36001971)
26. Schmidt-Ott KM, Mori K, Li JY et al.: Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 18, 407-413 (2007). (Pubitemid 46193306)
27. Flo TH, Smith KD, Sato S et al.: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestering iron. Nature 432, 917-921 (2004). (Pubitemid 40037155)
28. Berger T, Togawa A, Duncan GS et al.: Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 103, 1834-1839 (2006). (Pubitemid 43228779)
29. Yang J, Goetz D, Li JY et al.: An iron delivery pathway mediated by a lipocalin. Mol. Cell 10, 1045-1056 (2002). (Pubitemid 35453824)
30. Yang J, Blum A, Novak T, Levinson R, Lai E, Barasch J: An epithelial precursor is regulated by the ureteric bud and by the renal stroma. Dev. Biol. 246, 296-310 (2002). (Pubitemid 34775348)
31. Meldrum KK, Hilw K, Meldrum DR et al.: Simulated ischemia induced renal tubular cell apoptosis through a nuclear factor-kB dependent mechanism. J. Urol. 168, 248-252 (2002).
32. Haussler U, von Wichert G, Schmid RM et al.: Epidermal growth factor activates nuclear factor-kB in human proximal tubule cells. Am. J. Physiol. Renal Physiol. 280, F808-F815 (2005). (Pubitemid 41324202)
33. Mishra J, Mori K, Ma Q et al.: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 15, 3073-3082 (2004). (Pubitemid 39578839)
34. Devarajan P: Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther. 5(B), 463-470 (2007).
35. Devarajan P: The promise of biomarkers for personalized renal cancer care. Kidney Int. (2010) (In Press).
36. Supavekin S, Zhang W, Kucherlapati R et al.: Differential gene expression following early renal ischemia-reperfusion. Kidney Int. 63, 1714-1724 (2003). (Pubitemid 36513317)
37. Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS: Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol. Genet. Metab. 80(4), 365-376 (2003). (Pubitemid 37491197)
38. Yuen PST, Jo S-K, Holly MK et al.: Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol. Genomics 25, 375-386 (2006).
39. Mishra J, Ma Q, Prada A et al.: Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J. Am. Soc. Nephrol. 4, 2534-2543 (2003). (Pubitemid 37169339)
40. Mishra J, Mori K, Ma Q et al.: Neutrophil gelatinase-associated lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am. J. Nephrol. 24, 307-315 (2004). (Pubitemid 39070114)
41. Mori K, Lee HT, Rapoport D et al.: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 115, 610-621 (2005). (Pubitemid 40322235)
42. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J: Independent association between acute renal failure and mortality following cardiac surgery. Am. J. Med. 104, 343-348 (1998). (Pubitemid 28211024)
43. Lassnigg A, Schmidlin D, Mouhieddine M et al.: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J. Am. Soc. Nephrol. 15, 1597-1605 (2004). (Pubitemid 38679685)
44. Loef BG, Epema AH, Smilde TD et al.: Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J. Am. Soc. Nephrol. 16, 195-200 (2005).
45. Bellomo R, Auriemma S, Fabbri A et al.: The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int. J. Artif. Organs 31(2), 166-178 (2008). (Pubitemid 351425014)
46. Mishra J, Dent C, Tarabishi R et al.: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 365, 1231-1238 (2005). (Pubitemid 40469655)
47. Parikh CR, Mishra J, Thiessen-Philbrook H et al.: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 70, 199-203 (2006). (Pubitemid 44000139)
48. Portilla D, Dent C, Sugaya T et al.: Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 73, 465-472 (2008). (Pubitemid 351186293)
49. Wagener G, Jan M, Kim M et al.: Association between increases in urinary neutrophil-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105, 485-491 (2006). (Pubitemid 44310430)
50. Koyner J, Bennett M, Worcester E et al.: Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 74(8), 1059-1069 (2008).
51. Wagener G, Gubitosa G, Wang S et al.: Urinary neutrophil-associated lipocalin and acute kidney injury after cardiac surgery. Am. J. Kidney Dis. 52(3), 425-433 (2008). (Pubitemid 351571117)
52. Xin C, Yulong X, Yu C et al.: Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren. Fail. 30, 904-913 (2008).
53. Tuladhar SM, Puntmann VO, Soni M et al.: Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J. Cardiovasc. Pharmacol. 53, 261-266 (2009).
54. Haase-Fielitz A, Bellomo R, Devarajan P et al.: Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - a prospective cohort study. Crit. Care Med. 37(2), 553-560, (2009).
55. Haase M, Bellomo R, Devarajan P et al.: Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann. Thorac. Surg. 88(1), 124-130 (2009).
56. Haase-Fielitz A, Bellomo R, Devarajan P et al.: The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol. Dial. Transplant. 24(11), 3349-3354 (2009).
57. Devarajan P: NGAL in acute kidney injury: from serendipity to utility. Am. J. Kidney Dis. 52, 395-399 (2008). (Pubitemid 351398278)
58. Bellomo R, Ronco C, Kellum JA et al.: Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit. Care 8, R204-R212 (2004).
59. McIlroy DR, Wagener G, Lee HT: Neutrophil Gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin. J. Am. Soc. Nephrol. 5(2), 211-219 (2010).
60. Haase M, Bellomo R, Devarajan P et al.: Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54(6), 1012-1024 (2009).
61. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 364, 1814-1827 (2004). (Pubitemid 39488068)
62. Halloran PF, Hunsicker LG: Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am. J. Transplant. 1, 115-120 (2001).
63. Mishra J, Ma Q, Kelly C et al.: Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr. Nephrol. 21, 856-863 (2006). (Pubitemid 43740956)
64. Parikh CR, Jani A, Mishra J et al.: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am. J. Transplant. 6, 1639-1645 (2006). (Pubitemid 43945804)
65. Hall IE, Yarlagadda SG, Coca SG et al.: IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J. Am. Soc. Nephrol. 21(1), 189-197 (2010).
66. Kusaka M, Kuroyanagi Y, Mori T et al.: Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant. 17, 129-134 (2008). (Pubitemid 351551388)
67. Pannu N, Wiebe N, Tonelli M: Prophylaxis strategies for contrast-induced nephropathy. JAMA 295, 2765-2779 (2006). (Pubitemid 43920730)
68. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39, 930-936 (2002). (Pubitemid 34454211)
69. Solomon R: Contrast media nephropathy - how to diagnose and how to prevent? Nephrol. Dial. Transplant. 22(7), 1812-1815 (2007). (Pubitemid 47244745)
70. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E et al.: Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am. J. Nephrol. 26, 287-292 (2006). (Pubitemid 44121091)
71. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E et al.: Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography. Nephrol. Dial. Transplant. 22, 295-296 (2007). (Pubitemid 46050378)
72. Ling W, Zhaohui N, Ben H et al.: Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron. Clin. Pract. 108, c176-c181 (2008). (Pubitemid 351588109)
73. Hirsch R, Dent C, Pfriem H et al.: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr. Nephrol. 22, 2089-2095 (2007). (Pubitemid 350090716)
74. Joannidis M, Metnitz B, Bauer P et al.: Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 35(10), 1692-1702 (2009).
75. Guerin C, Girard R, Selli JM et al.: Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Am. J. Respir. Crit. Care Med. 161, 872-879 (2000). (Pubitemid 30171745)
76. Bagshaw SM, George C, Bellomo R: Early acute kidney injury and sepsis: a multicentre evaluation. Crit. Care 12, R47 (2008). (Pubitemid 351567061)
77. Zappitelli M, Washburn KM, Arikan AA et al.: Urine NGAL is an early marker of acute kidney injury in critically ill children. Crit. Care 11, R84 (2007). (Pubitemid 46741996)
78. Wheeler DS, Devarajan P, Ma Q et al.: Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit. Care Med. 36, 1297-1303 (2008). (Pubitemid 351482681)
79. Makris K, Markou N, Evodia E et al.: Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin. Chem. Lab. Med. 47(1), 79-82 (2009).
80. Siew ED, Ware LB, Gebretsadik T et al.: Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J. Am. Soc. Nephrol. 20(8), 1823-1832 (2009).
81. Cruz DN, de Cal M, Garzotto F et al.: Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Int. Care Med. 36(3), 444-451 (2009).
82. Bagshaw SM, Bennett M, Haase M et al.: Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Int. Care Med. 36(3), 452-461 (2009).
83. Constantin JM, Futier E, Perbet S et al.: Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J. Crit. Care (2009) (Epub ahead of print).
84. Niemann CU, Walia A, Waldman J et al.: Acute kidney injury during Liver Transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transplant. 15, 1852-1860 (2009).
85. Nickolas TL, O'Rourke MJ, Yang J et al.: Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann. Intern. Med. 148, 810-819 (2008). (Pubitemid 351786928)
86. Boldt J, Brosch C, Ducke M et al.: Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit. Care Med. 35, 2740-2746 (2007). (Pubitemid 350175770)
87. Boldt J, Brosch CH, Rohm K et al.: Comparison of the effects of gelatin and a modern hydroxyethylstarch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br. J. Anaesth. 100, 457-464 (2008). (Pubitemid 351773609)
88. Boldt J, Suttner S, Brosch C et al.: Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth. Analg. 109(6), 1752-1762 (2009).
89. Haase M, Fielitz-Haase A, Bellomo R et al.: Sodium bicarbonate to prevent acute kidney injury after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit. Care Med. 37(1), 39-47 (2009).
90. Capuano F, Goracci M, Luciani R et al.: Neutrophil gelatinase-associated lipocalin levels after use of mini-cardiopulmonary bypass system. Interact. Cardiovasc. Thorac. Surg. 9(5), 797-801 (2009).
91. Wagener G, Gubitosa G, Wang S et al.: Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL. Am. J. Nephrol. 28, 576-582 (2008). (Pubitemid 351832444)
92. Dent CL, Ma Q, Dastrala S et al.: Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit. Care 11, R127 (2007).
93. Bennett M, Dent CL, Ma Q et al.: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin. J. Am. Soc. Nephrol. 3, 665-673 (2008).
94. Trachtman H, Christen E, Cnaan A et al.: Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr. Nephrol. 21, 989-994 (2006). (Pubitemid 43885099)
95. Kumpers P, Hafer C, Lukasz A et al.: Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit. Care 14, R9 (2010).
96. Schaub S, Mayr M, Hönger G et al.: Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation 84, 104-112 (2007). (Pubitemid 47094649)
97. Grenier FC, Ali S, Syed H et al.: Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin. Biochem. (2009) (Epub ahead of print).
98. Haase-Fielitz A, Haase M, Bellomo R: Instability of urinary NGAL during long-term storage. Am. J. Kidney Dis. 53, 564-565 (2009).
99. Ma Q, Devarajan P: Induction of proapoptotic Daxx following ischemic acute kidney injury. Kidney Int. 74, 310-318 (2008). (Pubitemid 352001251)
100. Srichai MB, Hao C, Davis L et al.: Apoptosis of the thick ascending limb results in acute kidney injury. J. Am. Soc. Nephrol. 19, 1538-1546 (2008).
101. Grigoryev DN, Liu M, Hassoun HT et al.: The local and systemic inflammatory transcriptome after acute kidney injury. J. Am. Soc. Nephrol. 19, 547-558 (2008). (Pubitemid 351355398)
102. Mitsnefes M, Kathman T, Mishra J et al.: Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr. Nephrol. 22, 101-108 (2007).
103. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS et al.: Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patents with coronary artery disease. Nephrology (Carlton) 13, 153-156 (2008). (Pubitemid 351232835)
104. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E et al.: Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Ren. Fail. 30, 1-4 (2008). (Pubitemid 351232835)
105. Hemdahl A-L, Gabrielsen A, Zhu C et al.: Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 26, 136-142 (2006). (Pubitemid 43732240)
106. Folkesson M, Kazi M, Zhu C et al.: Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb. Haemost. 98(2), 427-433 (2007) (Pubitemid 47250247)
107. Bolignano D, Lacquaniti A, Coppolino G et al.: Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press. Res. 31, 255-258 (2008).
108. Bolignano D, Coppolino G, Campo S et al.: Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol. Dial. Transplant. 23, 414-416 (2008). (Pubitemid 351767366)
109. Bolignano D, Lacquaniti A, Coppolino G et al.: Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4(2), 337-344 (2009).
110. Ding H, He Y, Li K et al.: Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin. Immunol. 123, 227-234 (2007). (Pubitemid 46613869)
111. Brunner HI, Mueller M, Rutherford C et al.: Urinary NGAL as a biomarker of nephritis in childhood-onset SLE. Arthritis Rheum. 54, 2577-2584 (2006).
112. Suzuki M, Wiers KM, Klein-Gitelman MS et al.: Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr. Nephrol. 23, 403-412 (2008).
113. Hinze CH, Suzuki M, Klein-Gitelman M et al.: Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 60(9), 2772-2781 (2009).
114. Yilmaz A, Sevketoglu E, Gedikbasi A et al.: Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr. Nephrol. 24(12), 2387-2392 (2009).
115. Braunwald E. Biomarkers in heart disease. N. Engl. J. Med. 358, 2148-2159 (2008).
116. Peacock WF 4th, De Marco T, Fonarow GC et al.: Cardiac troponin and outcome in acute heart failure. N. Engl. J. Med. 358, 2117-2126 (2008). (Pubitemid 351679598)